StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) income statement

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-0.08%)

Close on Nov 18, 2026Market cap $383.32KP/E –Yield –

VivoSim Labs, INC. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
117.0%
Operating margin
-10117.0%
Net margin
-11016.1%
Return on equity, FY2026
-294.8%

Financial strength

Current ratio
1.70
Debt to equity
–
Debt to assets
–
Cash to current liabilities
88.2%

Valuation

P/E ratio
–
Price to sales
3.42
Price to book
–
Dividend yield
–

See a number that looks wrong?